severe mesangial proliferative glomerulonephritis相关文献:
Standardized classification and reporting of glomerulonephritis.
Sethi S, Fervenza FC.
Nephrol Dial Transplant. 2019 Feb 1;34(2):193-199. doi: 10.1093/ndt/gfy220.
PMID:30124958
Mesangial proliferative glomerulonephritis in southwestern American Indians.
Hoy WE, Hughson MD, Smith SM, Megill DM.
Am J Kidney Dis. 1993 May;21(5):486-96. doi: 10.1016/s0272-6386(12)80394-5.
PMID:8488816
Expression and clinical significance of thrombospondin-1 and plasminogen activator inhibitor-1 in patients with mesangial proliferative glomerulonephritis.
Pan C, Zhou C, Shan A, Chen N.
Ann Palliat Med. 2020 Sep;9(5):3187-3193. doi: 10.21037/apm-20-1291. Epub 2020 Aug 31.
PMID:32921106
CX3CR1(+) Monocytes/Macrophages Promote Regional Immune Injury in Mesangial Proliferative Glomerulonephritis through Crosstalk with Activated Mesangial Cells.
Zhang J, Fang Q, Huang Y, Qu Y, Liu Q, Li R, Zhou Y, Cui S, Liu R, Wang X, Bai Y, Duan S, Wu L, Chen P, Wang Y, Wu J, Sun X, Cai G, Zheng Y, Hong Q, Chen X.
Research (Wash D C). 2025 Jun 2;8:0716. doi: 10.34133/research.0716. eCollection 2025.
PMID:40458609
Pediatric Mesangial Proliferative Glomerulonephritis Has Increased the Platelet Thrombus Formation Potentials under High-Shear Flow Condition.
Omae T, Ishikawa T, Ogiwara K, Nogami K.
Nephron. 2024;148(6):415-425. doi: 10.1159/000534494. Epub 2023 Oct 9.
PMID:37812914
Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.
Horii Y, Iwano M, Hirata E, Shiiki M, Fujii Y, Dohi K, Ishikawa H.